Aptorum Group Limited (NASDAQ:APM) Sees Large Increase in Short Interest

Aptorum Group Limited (NASDAQ:APM) saw a significant growth in short interest during the month of November. As of November 15th, there was short interest totalling 13,100 shares, a growth of 184.8% from the October 31st total of 4,600 shares. Approximately 0.6% of the shares of the company are short sold. Based on an average daily trading volume, of 32,600 shares, the days-to-cover ratio is presently 0.4 days.

Aptorum Group Trading Up 5.5 %

Shares of NASDAQ:APM opened at $0.71 on Thursday. Aptorum Group has a fifty-two week low of $0.46 and a fifty-two week high of $17.49. The company’s 50-day moving average price is $1.47 and its 200 day moving average price is $2.98.

Aptorum Group Company Profile

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.